Longitudinal Screening of Mutant Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM) and Its Association with Secondary Primary Malignancies (SPM)

MLA

Perez, Cristina, et al. “Longitudinal Screening of Mutant Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM) and Its Association with Secondary Primary Malignancies (SPM).” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 533. EBSCOhost, https://doi.org/10.1182/blood-2023-185737.

APA

Perez, C., Larrayoz, M. J., Vazquez, I., Erdozain, I., Puig, N., Cedena, M. T., Maia, C., Mañu, A., Gordillo, N., Churruca, O., Alignani, D., Sarvide, S., Rocafiguera, A. O., Rosiñol, L., Ríos, R., Gonzalez Perez, M. S., Gonzalez-Rodriguez, A. P., De Arriba, F., Moraleda, J. M., … Paiva, B. (2023). Longitudinal Screening of Mutant Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM) and Its Association with Secondary Primary Malignancies (SPM). Blood, 142(1, Number 1 Supplement 1), 533. https://doi.org/10.1182/blood-2023-185737

Chicago

Perez, Cristina, Maria Jose Larrayoz, Iria Vazquez, Irache Erdozain, Noemi Puig, María T Cedena, Catarina Maia, et al. 2023. “Longitudinal Screening of Mutant Hematopoietic Progenitor Cells (HPC) in Multiple Myeloma (MM) and Its Association with Secondary Primary Malignancies (SPM).” Blood 142 (1, Number 1 Supplement 1): 533. doi:10.1182/blood-2023-185737.